Total Payments
$14,008
2024 Payments
$1,262
Companies
55
Transactions
298
Medicare Patients
17,371
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$7,886 (56.3%)
Consulting$4,680 (33.4%)
Travel$848.17 (6.1%)
Education$364.02 (2.6%)
Gifts$229.74 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,886 | 289 | 56.3% |
| Consulting Fee | $4,680 | 1 | 33.4% |
| Travel and Lodging | $848.17 | 1 | 6.1% |
| Education | $364.02 | 6 | 2.6% |
| Gift | $229.74 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $6,834 | 48 | $0 (2024) |
| NeoTract Inc. | $1,443 | 22 | $0 (2020) |
| Astellas Pharma US Inc | $804.89 | 51 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $408.12 | 16 | $0 (2024) |
| DENTSPLY IH AB | $327.50 | 12 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $281.93 | 12 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $275.62 | 7 | $0 (2024) |
| PFIZER INC. | $270.56 | 13 | $0 (2023) |
| NxThera, Inc. | $250.85 | 3 | $0 (2017) |
| Sumitomo Pharma America, Inc. | $234.43 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,262 | 40 | DENTSPLY IH AB ($236.16) |
| 2023 | $833.69 | 31 | Progenics Pharmaceuticals, Inc. ($156.14) |
| 2022 | $726.77 | 29 | Janssen Biotech, Inc. ($260.41) |
| 2021 | $555.86 | 18 | Myriad Genetic Laboratories, Inc. ($135.29) |
| 2020 | $356.81 | 14 | PFIZER INC. ($107.37) |
| 2019 | $1,810 | 63 | NeoTract Inc. ($767.01) |
| 2018 | $7,028 | 59 | Janssen Biotech, Inc. ($5,821) |
| 2017 | $1,436 | 44 | NeoTract Inc. ($380.37) |
All Payment Transactions
298 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Urology | ||||||
| 12/05/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $144.10 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $59.81 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/23/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: Oncology | ||||||
| 09/20/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $122.72 | General |
| Category: OS | ||||||
| 09/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: UROLOGY | ||||||
| 08/20/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: UROLOGY | ||||||
| 08/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $40.55 | General |
| Category: UROLOGY | ||||||
| 07/25/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: Oncology | ||||||
| 07/15/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $35.38 | General |
| Category: Medical Urology | ||||||
| 06/26/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 06/14/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Oncology | ||||||
| 06/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: UROLOGY | ||||||
| 06/08/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $38.44 | General |
| Category: UROLOGY | ||||||
| 05/08/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Oncology | ||||||
| 04/29/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Medical Urology | ||||||
| 04/25/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: ONCOLOGY | ||||||
| 04/16/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Medical Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 4,547 | 11,190 | $2.0M | $409,288 |
| 2022 | 49 | 4,706 | 10,684 | $2.1M | $439,064 |
| 2021 | 41 | 4,367 | 10,611 | $2.1M | $456,827 |
| 2020 | 40 | 3,751 | 5,437 | $1.8M | $358,806 |
Total Patients
17,371
Total Services
37,922
Medicare Billing
$1.7M
Procedure Codes
177
All Medicare Procedures & Services
177 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 677 | 1,223 | $428,050 | $116,310 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 520 | 827 | $202,615 | $55,045 | 27.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 181 | 219 | $158,775 | $40,817 | 25.7% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 193 | 383 | $99,025 | $18,892 | 19.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 15 | 127 | $95,250 | $17,000 | 17.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 141 | 141 | $67,230 | $16,552 | 24.6% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 22 | 22 | $77,000 | $11,839 | 15.4% |
| 50386 | Removal of stent in ureter through ureter with review by radiologist | Office | 2023 | 17 | 17 | $38,700 | $10,412 | 26.9% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 19 | 4,022 | $40,220 | $9,112 | 22.7% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 27 | 27 | $53,500 | $8,814 | 16.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 73 | 117 | $33,860 | $8,383 | 24.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 581 | 963 | $48,150 | $7,983 | 16.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 64 | 67 | $25,125 | $6,823 | 27.2% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 37 | 37 | $29,600 | $6,453 | 21.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 235 | 348 | $34,800 | $6,271 | 18.0% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 19 | 83 | $37,350 | $5,997 | 16.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 95 | $8,075 | $4,659 | 57.7% |
| 51705 | Simple change of bladder tube | Office | 2023 | 19 | 59 | $17,700 | $4,558 | 25.7% |
| 55706 | Needle biopsy of prostate gland using image guidance | Office | 2023 | 15 | 15 | $16,500 | $4,357 | 26.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 322 | 477 | $11,925 | $4,007 | 33.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 39 | 78 | $23,400 | $3,792 | 16.2% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 100 | 147 | $13,083 | $3,718 | 28.4% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Facility | 2023 | 25 | 26 | $91,000 | $3,504 | 3.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 22 | 24 | $55,000 | $2,964 | 5.4% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2023 | 46 | 77 | $18,400 | $2,897 | 15.7% |
About Dr. Michael Geffin, MD
Dr. Michael Geffin, MD is a Urology healthcare provider based in Plymouth, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578583902.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Geffin, MD has received a total of $14,008 in payments from pharmaceutical and medical device companies, with $1,262 received in 2024. These payments were reported across 298 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($7,886).
As a Medicare-enrolled provider, Geffin has provided services to 17,371 Medicare beneficiaries, totaling 37,922 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 177 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Plymouth, MA
- Active Since 07/20/2006
- Last Updated 01/16/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1578583902
Products in Payments
- Erleada (Drug) $5,979
- UroLift (Device) $1,063
- ERLEADA (Drug) $740.78
- XTANDI (Drug) $666.34
- Urolift - UL400 (Device) $380.37
- XIAFLEX (Biological) $349.79
- PROVENGE (Drug) $337.33
- PYLARIFY (Drug) $275.62
- GEMTESA (Drug) $268.71
- Rezum (Device) $250.85
- LOFRIC (Device) $236.16
- ELIGARD (Drug) $213.11
- Myrbetriq (Drug) $210.90
- ZYTIGA (Drug) $207.91
- SpaceOAR (Device) $139.00
- UROLIFT (Device) $134.02
- NANOKNIFE (Device) $122.72
- BRACAnalysis CDx (Device) $120.13
- Xtandi (Drug) $109.29
- PENILE RECONSTRUCTION (Device) $98.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.